Verve Therapeutics Inc.

In News

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - Eli Lilly

Eli Lilly - Jun 17, 2025

Eli Lilly acquires Verve Therapeutics in $1.3 billion deal, validating gene editing for heart disease - drugdiscoverytrends.com

drugdiscoverytrends.com - Jul 19, 2025

Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly - MSN

MSN - Jan 06, 2026

Eli Lilly to Acquire Verve Therapeutics to Advance One-Time Cardiovascular Treatments - CRISPR Medicine News

CRISPR Medicine News - Jun 17, 2025

Lilly and Verve announce expiration of Verve tender offer - PR Newswire

PR Newswire - Jul 24, 2025

Lilly to Acquire Verve Therapeutics for Up to $1.3B - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Jun 17, 2025

Lilly to Acquire Verve Therapeutics in $1.3B Deal Targeting One-Time Gene-Editing Treatments for Cardiovascular Disease - BioPharm International

BioPharm International - Jun 17, 2025

Why Verve Therapeutics Stock Is Skyrocketing Today - The Motley Fool

The Motley Fool - Jun 17, 2025

Lilly Acquires Verve Therapeutics - Contract Pharma

Contract Pharma - Jul 28, 2025

Verve Therapeutics Announces Positive Initial Data from the - GlobeNewswire

GlobeNewswire - Apr 14, 2025

Lilly to acquire Verve in $1B bet on gene editing for heart disease - BioPharma Dive

BioPharma Dive - Jun 17, 2025

Wilson Sonsini Advises Verve Therapeutics on IP Matters Related to Merger with Lilly - Wilson Sonsini

Wilson Sonsini - Jun 17, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment